One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1093/rheumatology/keab247.166
Copy DOI Journal: Rheumatology |  Publication Date: Apr 25, 2021 |
Affiliation: Medical Plus, University of Veterinary Sciences Brno, Probity Medical Research, Pontifical Catholic University of Rio Grande do Sul, AbbVie (United States), Ghent University Hospital, Royal National Hospital for Rheumatic Diseases, University of Washington, Swedish Medical Center, Osaka Minami Medical Center, Stanford UniversityP171 Efficacy and safety of upadacitinib in patients with active PsA and inadequate response to biologic DMARDs (SELECT-PsA-2): a double-blind, randomised controlled Phase III trial
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
